Trial Profile
Efficacy and tolerance of the Plitidepsine in patients with a dedifferencie Liposarcoma (DLPS) advanced, non-operable or metastatic in relapse/refractory: A multi-center exploratory phase II.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2012
Price :
$35
*
At a glance
- Drugs Plitidepsin (Primary)
- Indications Liposarcoma
- Focus Biomarker; Therapeutic Use
- 14 Jun 2011 New trial record